Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PURITAN MEDICAL

Agreement to Promote Development of Single-Use Biomass Sensors

By BiotechDaily International staff writers
Posted on 11 Mar 2013
A recently announced marketing and development agreement focuses on single-use biosensors that are used by the biopharmaceutical industry for obtaining in-line biomass measurements during cell cultivation and fermentation processes.

Sartorius Stedim Biothech (Aubagne, France), a leading provider of equipment and services for development, quality assurance, and production in the biopharmaceutical industry, will be cooperating with Aber Instruments (Aberystwyth, United Kingdom), a global leader in in-line biomass measurement technology. Biomass sensors are high-performance tools for modeling and optimizing biopharmaceutical development and manufacturing processes.

The agreement will give Sartorius exclusive global marketing and distribution rights to Aber's single-use sensor technology for the biopharmaceutical market. Sartorius will manufacture the biomass sensors under license, integrate these into its single-use bioreactors, and exclusively market these products in a dual-branding arrangement. New single-use sensors will be developed by both companies.

"Single-use sensors make our disposable bags even more intelligent," said Stefan Schlack, senior vice president of marketing at Sartorius Stedim Biothech. "They deliver real-time information about the progress of cell culture processes and help biopharmaceutical customers to understand their processes even better and further optimize them – a decisive competitive advantage."

Dr. John Carvell, sales and marketing director at Aber Instruments, said, "Based on Sartorius Stedim Biothech's global sales and distribution network, we can make our technology accessible to an even wider group of customers. Sartorius has in-depth expertise in single-use technology and is thoroughly versed in bioprocesses. Together with our profound knowledge of in-line biomass measurement, both companies stand to benefit from the joint development of new sensors.”

Related Links:

Sartorius Stedim Biothech
Aber Instruments




Channels

Genomics/Proteomics

view channel
Image: Researchers have generated disease-free stem cells from patients with mitochondrial disease that can be converted into any cell type including neuronal progenitors (left) or heart cells (right). These could potentially be used for future transplantation into patients (Photo courtesy of Salk Institute of Biological Studies).

Methods Developed to Generate Normal Stem Cells from Patients with Mitochondrial Defects

A recent paper described two methods for converting cells from patients with mitochondrial defects into normal pluripotent stem cells that could be induced to differentiate into several different types of tissues.... Read more

Drug Discovery

view channel
Image: A new micelle delivery system for the protective polyphenols resveratrol and quercetin (mRQ) may have value in cancer chemotherapy (Photo courtesy of Oregon State University).

Micelles Containing Resveratrol and Quercetin Reverse Doxorubicin Cardiotoxicity

Cancer researchers blocked the toxic effects of the cancer drug doxorubicin (DOX) by administering it together with the plant antioxidants resveratrol and quercetin. Although in use for more than 40... Read more

Business

view channel

Teva Buys Allergan Generic Business Unit

Teva Pharmaceutical Industries (Petah Tikva, Israel) has bought the Allergan (Irvine, CA, USA) generic drugs business for USD 40.5 billion in cash and stock, solidifying its position as the world's largest generic drug maker. Under the terms of the agreement, Teva will pay USD 33.75 billion in cash and USD 6.... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.